Drug Search Results
More Filters [+]

Carbenoxolone

Alternative Names: carbenoxolone
Latest Update: 2024-05-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: 11beta-HSD1 Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Dominican Republic | Hong Kong | Hungary | India | Ireland | Malaysia | New Zealand | Peru | Philippines | Portugal | Spain | Taiwan | United Arab Emirates | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: University Hospitals Birmingham NHS Trust
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Carbenoxolone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2006-003426-28

P2

Terminated

Unknown

2011-02-08

Recent News Events